Redefining “High-Risk” Multiple Myeloma with New Genetic Insights – International Myeloma Foundation
International Myeloma Foundation (IMF) shared a post on X about a paper by Nikhil C. Munshi et al. published in the Journal of Clinical Oncology:
“We’ve redefined ‘high-risk’ multiple myeloma with new genetic insights, enabling earlier, personalized treatment and smarter research. Better definitions mean better care for you.”
Title: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma
Authors: Hervé Avet-Loiseau, Faith E. Davies, Mehmet K. Samur, Jill Corre, Mattia D’Agostino, Martin F. Kaiser, Marc S. Raab, Niels Weinhold, Norma C. Gutierrez, S. Bruno Paiva, Paola Neri, Katja Weisel, Francesco Maura, Brian A. Walker, Mark Bustoros, A. Keith Stewart, Saad Z. Usmani, Jens Hillengass, Wee Joo Chng, Jonathan J. Keats, Joaquin Martinez-Lopez, Adam S. Sperling, Cyrille Touzeau, Fenghuang Zhan, Noopur S. Raje, Michele Cavo, Niccolò Bolli, Irene M. Ghobrial, Madhav V. Dhodapkar, Sundar Jagannath, Andrew Spencer, Samir Parekh, Nizar J. Bahlis, Sagar Lonial, Pieter Sonneveld, Leif Bergsagel, Robert Z. Orlowski, Gareth Morgan, María Victoria Mateos, S. Vincent Rajkumar, Jesus F. San Miguel, Kenneth C. Anderson, Philippe Moreau, Shaji Kumar, Felipe Prósper, Nikhil C. Munshi.
You can read the Full Article in the Journal of Clinical Oncology.
More posts featuring International Myeloma Foundation.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023